Listed by the USPTO as YOO, SUN JAE
Tech Center 1600 • Art Units: 1621 1622 1626 1647 1674
This examiner grants 71% of resolved cases
YOO, SUN JAE is assigned to tech center 1600 and art unit 1621. The profile covers 1241 resolved cases, with an allowance rate of 71.2% and a median of 995 days to allowance. The interview lift is 0.3%, indicating little association between interviews and allowance outcomes.
BASF, Kuleon, and Spero Therapeutics are the listed companies. The listed firms are Culhane Meadows PLLC, GREENBERG TRAURIG, LLP (BOS), and MARSHALL, GERSTEIN & BORUN LLP. The record supports relying primarily on clear written prosecution, with interviews used when they address a specific unresolved issue.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18399092 | 6-PHENYL-4,5-DIHYDROPYRIDAZIN-3(2H)-ONE DERIVATIVES AS PDE3A AND PDE3B INHIBITORS FOR TREATING CANCER | Non-Final OA | Dana-Farber Cancer Institute, Inc. |
| 17995874 | CRYSTALLINE FORMS OF AN APOPTOSIS-INDUCING AGENT | Non-Final OA | AbbVie Inc. |
| 18584311 | SODIUM CHANNEL INHIBITORS AND METHODS OF DESIGNING SAME | Non-Final OA | Genentech, Inc. |
| 18293003 | (3-PIRYDYL)-QUINAZOLINE | Non-Final OA | BASF SE |
| 18272673 | SYNTHESIS OF POLYFLUORINATED ARYL AND HETEROARYL CARBOXAMIDES | Non-Final OA | BASF SE |
| 18697706 | INHIBITORS OF ALPHA-5 BETA-1 INTEGRIN AND USES THEREOF | Non-Final OA | The Regents of the University of California |
| 17912485 | SELECTIVE NON-CYCLIC NUCLEOTIDE ACTIVATORS FOR THE CAMP SENSOR EPAC1 | Final Rejection | The Board of Regents of The University of Texas System |
| 18564748 | COMPOUNDS FOR THE TREATMENT OF SARS | Non-Final OA | Purdue Research Foundation |
| 18684225 | Amorphous Form of (S)-2-(5-((3-Ethoxypyridin-2-YL)Oxy)Pyridin-3-YL)-N-(Tetrahydrofuran-3-YL)Pyrimidine-5-Carboxamide | Non-Final OA | Pfizer Inc. |
| 18296538 | ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME | Non-Final OA | ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy71.2% of resolved applications examined by Sun Jae Yoo were allowed (1,241 resolved cases), compared with 46.0% across Art Unit 1621 over the last five years.
This examiner's interview lift is +0.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Sun Jae Yoo took 995 days on average from filing to allowance.
Sun Jae Yoo examines applications in Art Unit 1621 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
